Olfr768, encoded by the Or6c38 gene, is an olfactory receptor belonging to the large and diverse family of G-protein-coupled receptors (GPCRs) in Mus musculus (house mouse). As a critical component of the olfactory system, Olfr768 plays a significant role in the detection and transduction of odorant signals. The unique functional attributes of Olfr768 and other olfactory receptors stem from their ability to interact with a wide range of odorant molecules, initiating neuronal responses that culminate in the perception of smell. The 7-transmembrane domain structure of Olfr768, shared with many neurotransmitter and hormone receptors, is key to its functionality. This structure facilitates the recognition of specific odorant molecules and the subsequent activation of associated G proteins, which then trigger a cascade of intracellular signaling events leading to neuronal excitation and signal transmission.
The inhibition of Olfr768, and by extension, the modulation of olfactory perception, can be achieved through various mechanisms that primarily target GPCR signaling pathways. Given the extensive signaling networks in which GPCRs are involved, there are multiple points of intervention for potential inhibitors. Chemical inhibitors, like those listed above, can exert their effects either directly on Olfr768 or indirectly through other components of the GPCR signaling pathways. For instance, antagonists of beta-adrenergic receptors, such as propranolol and carvedilol, may indirectly modulate the function of olfactory receptors by influencing the overall dynamics of GPCR signaling. This could include changes in receptor conformation, availability, or the efficiency of G protein coupling, which are crucial for receptor activation and signal transduction. Similarly, inhibitors targeting other GPCRs, such as serotonin or angiotensin receptors, can create a ripple effect within the GPCR superfamily. This indirect mode of action arises from the interconnected nature of cellular signaling pathways, where modulation of one receptor type can influence the behavior of others, including olfactory receptors. In summary, the inhibition of Olfr768, a key player in the olfactory system, can be approached through a strategic modulation of GPCR-related pathways. The selection and application of specific chemical inhibitors offer a method to influence olfactory perception by altering the functional dynamics of Olfr768 and related receptors. This approach underscores the complexity and interconnectivity of GPCR signaling, highlighting the potential for targeted interventions in the realm of sensory perception and beyond.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a non-selective beta-adrenergic receptor antagonist. It impedes adrenergic signaling, which can indirectly modulate GPCR activity including that of olfactory receptors by altering receptor conformation and availability. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $124.00 $240.00 $530.00 $999.00 $1530.00 | 2 | |
Carvedilol acts as a non-selective beta-adrenergic blocker with alpha-1 blocking activity. This duality influences GPCR signaling pathways, potentially affecting olfactory receptor functions by altering G protein coupling efficiency. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan is an angiotensin II receptor antagonist that impacts GPCR signaling. Its blockade of angiotensin receptors can indirectly influence olfactory GPCR dynamics through crosstalk within the GPCR superfamily. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $82.00 $333.00 | 1 | |
Ondansetron is a serotonin 5-HT3 receptor antagonist. By impeding serotonin signaling, it can indirectly affect GPCR-mediated pathways, potentially modulating the activity of olfactory receptors. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine is an alpha-2 adrenergic receptor antagonist. Its inhibition of adrenergic receptors can lead to altered GPCR signaling, which may indirectly influence the functional dynamics of olfactory receptors. | ||||||
Ritanserin | 87051-43-2 | sc-203681 sc-203681A | 10 mg 50 mg | $89.00 $312.00 | 2 | |
Ritanserin is a selective serotonin 5-HT2A receptor antagonist. This selective inhibition of serotonin receptors can indirectly modulate other GPCR family members, including olfactory receptors. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $107.00 $243.00 | 3 | |
Metoprolol is a selective beta-1 adrenergic receptor blocker. It specifically targets cardiac adrenergic receptors, potentially influencing GPCR-mediated olfactory signaling through systemic adrenergic modulation. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $79.00 $416.00 | 1 | |
Atenolol, a selective beta-1 adrenergic receptor antagonist, affects heart rate and blood pressure. This selective action can indirectly impact GPCR signaling pathways, including those involved in olfactory perception. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $180.00 | ||
Labetalol acts as both a beta-adrenergic and alpha-1 adrenergic receptor blocker. This dual antagonism can affect GPCR signaling in a way that potentially modulates olfactory receptor activity. | ||||||
Nebivolol | 99200-09-6 | sc-279910 | 100 mg | $803.00 | 1 | |
Nebivolol is a selective beta-1 adrenergic receptor antagonist with nitric oxide-potentiating vasodilatory effect. Its influence on adrenergic pathways can indirectly affect GPCR signaling relevant to olfactory receptors. | ||||||